Vitiligo
RecruitingStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
- Disease:Vitiligo
- Substances:Ruxolitinib
Spain- Participants:0–17 years
- Substances:Ruxolitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
Back to Spain3 291 clinical trials in Madrid, Spain across 24 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Investigating novel treatments for cutaneous lupus erythematosus and immune thrombocytopenia, with studies evaluating new therapeutic approaches to manage these challenging conditions.
Research focuses on improving treatment outcomes and quality of life for patients with autoimmune disorders.
Clinical trials examining innovative therapies for Type 1 Diabetes in combination with weight management, targeting both glycemic control and obesity-related complications.
Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.
Breakthrough research in multiple sclerosis and acute ischemic stroke, exploring new therapeutic options for both pediatric and adult populations.
Focus on developing targeted treatments to improve neurological outcomes and patient care.
Comprehensive vaccine studies targeting respiratory syncytial virus, influenza, and herpes zoster, with particular attention to vulnerable populations.
Research aims to enhance protection against common and serious infectious diseases.
Innovative studies in mantle cell lymphoma and bladder cancer, exploring combination therapies and targeted treatments to improve patient outcomes.
Focus on developing more effective and personalized cancer treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.